Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FE.1.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FE.1.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FE.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.94EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.94EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.94ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.94ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.94EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.94EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.94ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.94ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GK.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FL.15.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.15.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.15.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.15.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.15.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.15.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.9.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.9.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.9.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.9.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.9.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GJ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GJ.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GJ.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GJ.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GJ.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used